Biostar Pharmaceuticals is a holding company. Through its wholly-owned subsidiary, Shaanxi Biostar Biotech, Ltd. and its variable interest entities Shaanxi Aoxing Pharmaceutical Co., Ltd. and Shaanxi Weinan Huaren Pharmaceuticals Ltd., Co. develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in China. Co.'s primary product is the XinAoxing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. As of Dec 31 2016, Co. manufactured and sold 12 OTC medications and 17 prescription-based pharmaceuticals which were sold and distributed in over 25 provinces and provincial-level cities throughout China.
|
Free BSPM Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |